Co-amplification of erbB2, topoisomerase II α and retinoic acid receptor α genes in breast cancer and allelic loss at topoisomerase I on chromosome 20
- 1 January 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (10) , 1469-1475
- https://doi.org/10.1016/0959-8049(93)90022-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- DNA topoisomerase-targeting antitumor agents and drug resistanceAnti-Cancer Drugs, 1992
- Amplification of the topoisomerase ii α gene in a non‐small cell lung cancer cell line and characterisation of polymorphisms at the human topoisomerase ii α and β loci in normal tissueGenes, Chromosomes and Cancer, 1992
- Report of the Third International Workshop on Human Chromosome 17 Mapping 1992Cytogenetic and Genome Research, 1992
- The role of DNA topoisomerases in recombination and genome stability: A double-edged sword?Cell, 1990
- 4. The role of the epidermal growth factor receptor and the c-erbB-2 protein in breast cancerInternational Journal of Cancer, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Mapping of the human retinoic acid receptor to the q21 band of chromosome 17Human Genetics, 1988
- Localization and linkage of three polymorphic DNA sequences on human chromosome 20Cytogenetic and Genome Research, 1986
- The Complete Primary Structure of Protein Kinase C—the Major Phorbol Ester ReceptorScience, 1986
- Hematologic manifestations associated with deletions of the long arm of chromosome 20Cancer Genetics and Cytogenetics, 1984